首页 | 本学科首页   官方微博 | 高级检索  
     

提前肝素化和超选择冠状动脉内注入替罗非班对STEMI患者PCI的影响*
引用本文:吴方辉,张江武,刘金来,许云耀,侯冬子,林凯平,黄世安,孔伟龙. 提前肝素化和超选择冠状动脉内注入替罗非班对STEMI患者PCI的影响*[J]. 中国现代医学杂志, 2019, 29(7): 92-96
作者姓名:吴方辉  张江武  刘金来  许云耀  侯冬子  林凯平  黄世安  孔伟龙
作者单位:(1.中山大学附属第三医院粤东医院 心血管内科,广东 梅州 514700;2.中山大学附属第三医院 心血管内科,广东 广州 510630;3.华城人民医院 内科,广东 梅州 514471)
基金项目:广东省梅州市市级医研类科技计划项目(No:2016B118)
摘    要:目的 评价提前肝素化和超选择冠状动脉内注入替罗非班对急性ST段抬高心肌梗死(STEMI)患者经皮冠脉介入术(PCI)的影响。方法 选取2016年1月—2018年12月中山大学附属第三医院粤东医院STEMI患者行急诊PCI共120例,随机将其分为对照组和观察组各60例。对照组采用常规PCI程序,观察组采用提前肝素化、直接用指引导管造影和超选择冠状动脉内注入替罗非班。比较两组靶血管TIMI血流3级的校正帧数,术后90?min的心电图ST段回落率,入院后30?min、6、12、24、36和48?h的心肌型酸酶同工酶(CK-MB)和血清心肌肌钙蛋白I(cTn?I)值和到达峰值时间,住院期间主要心脏不良事件(MACE)和严重出血事件。结果 观察组与对照组比较,TIMI校正帧数减小,ST段回落率增加,CK-MB和cTn?I的峰值降低,峰值时间提前,MACE发生率降低,差异有统计学意义(P?<0.05)。两组严重出血事件比较差异无统计学意义(P?>0.05)。结论 提前肝素化和超选择冠状动脉内注入替罗非班对STEMI患者急诊PCI可缩短缺血心肌再灌注时间,增加心肌存活,改善近期预后。

关 键 词:ST段抬高心肌梗死/心肌梗塞;肝素;冠状动脉;替罗非班/纤维蛋白溶解药;经皮冠脉介入术/心血管外科手术
收稿时间:2018-09-29

Effect of earlier heparinize and intracoronary infusion of Tirofiban on PCI in patients with acute ST segment elevated myocardial infarction*
Fang-hui Wu,Jiang-wu Zhang,Jin-lai Liu,Yun-yao Xu,Dong-zi Hou,Kai-ping Lin,Shi-an Huang,Wei-long Kong. Effect of earlier heparinize and intracoronary infusion of Tirofiban on PCI in patients with acute ST segment elevated myocardial infarction*[J]. China Journal of Modern Medicine, 2019, 29(7): 92-96
Authors:Fang-hui Wu  Jiang-wu Zhang  Jin-lai Liu  Yun-yao Xu  Dong-zi Hou  Kai-ping Lin  Shi-an Huang  Wei-long Kong
Abstract:Objective To study effect of early heparinize and intracoronary infusion of Tirofiban on PCI treatment in patients with acute ST segment elevated myocardial infarction (STEMI). Methods A total of 120 cases with acute STEMI received PCI in the Third Affiliated Hospital of Sun Yat-Sen University-Yuedong Hospital during January 2016 to December 2018. Patients were enrolled in this study and were divided randomly into control group and observation group (n?=?60). Patients in control group received routine PCI procedure. Patients in observation group received early heparinize and intracoronary infusion of tirofiban. Corrected frames to TIMI blood flow of level 3 in target vessel, ST segment recovery rate in electrocardiogram after operation 90-min, peak value and time of CK-MB and cTnI at various timepoint (30 min, 6 h, 12 h, 24 h, 36 h and 48 h), major adverse cardiac events were recorded. Results Patients in observation group experienced significant decrease in the TIMI corrected frames, peak value and time of CK-M and cTnI (P??0.05). Conclusions Early heparinize and intracoronary infusion of Tirofiban shorten reperfusion time of ischemic myocardium, improving outcome of patients with acute STEMI.
Keywords:ST segment elevated myocardial infarction/myocardial infarction   heparin   coronary artery   Tirofiban/fibrin dissolving drug   percutaneous coronary intervention/cardiovascular surgery
点击此处可从《中国现代医学杂志》浏览原始摘要信息
点击此处可从《中国现代医学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号